MENU
CGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Compugen (CGEN) Ownership - Who owns Compugen?

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
75
Web
https://www.cgen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
188.77M
P/E Ratio
5.33
Total Cash
134.95M
Projected Growth
N/A
Total Debt
2.93M
Revenue
72.66M
Risk (Beta)
2.65
Dividend Yield
N/A
Total Cash/Share
1.43
Total Debt/Equity
N/A
Revenue/Share
0.77 USD as % of share price
View a ticker or compare two or three
CGEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a maker of drug and diagnostics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
75
Web
https://www.cgen.com